https://www.selleckchem.com/products/ABT-888.html
007) and there was an association between an increase in treatment and compliance to IBD home (multivariate odds ratio 3.22; 95 confidence interval 1.04 - 9.95). Overall patients reported a positive experience with slight technical difficulties. Self-monitoring with home based fecal calprotectin and a digital application was found feasible and appreciated by compliers. Compliance to the IBD-Home model was more common in women and associated with an increased treatment for IBD. Self-monitoring with home based fecal calprotectin and a dig